Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

Mise à jour : Il y a 4 ans
Référence : NCT00107978

Femme et Homme

Extrait

Study 0018 (NCT00107978) compares the safety and effectiveness of an investigational drug, telavancin, and an approved drug, vancomycin, for the treatment of complicated skin and skin structure infections.


Critère d'inclusion

  • Staphylococcal Skin Infection

Liens